Cargando…

RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis

Male osteoporosis is an increasingly recognized problem in aging men. A common cause of male osteoporosis is hypogonadism. Thousands of men with prostate cancer are treated with androgen deprivation therapy, a treatment that dramatically reduces serum testosterone and causes severe hypogonadism. Men...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgans, Alicia K., Smith, Matthew R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196262/ https://www.ncbi.nlm.nih.gov/pubmed/22013547 http://dx.doi.org/10.4061/2011/941310

Ejemplares similares

Role of RANKL inhibition in osteoporosis
por: McClung, Michael
Publicado: (2007)

The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies
por: Kim, Ted, et al.
Publicado: (2023)

Frontiers in hormone therapy for male infertility
por: Khourdaji, Iyad, et al.
Publicado: (2018)

Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy
por: Zhang, Ning, et al.
Publicado: (2020)

Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis
por: Huang, Dane, et al.
Publicado: (2022)

Polymer therapeutics in surgery: the next frontier
por: Azzopardi, Ernest A., et al.
Publicado: (2016)

Next frontiers in CAR T-cell therapy
por: Brown, Christine E, et al.
Publicado: (2016)

Targeting RANKL in metastasis
por: Dougall, William C, et al.
Publicado: (2014)

The Next Frontiers
por: Porcino, Antony
Publicado: (2013)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
por: Chi, Guanghao, et al.
Publicado: (2023)

Retinal Diseases: The Next Frontier in Pharmacodelivery
por: Ben-Arzi, Assaf, et al.
Publicado: (2022)

Microbiome: The Next Frontier in Psychedelic Renaissance
por: Kargbo, Robert B.
Publicado: (2023)

MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation
por: Benitez, Cecil M., et al.
Publicado: (2023)

Systems Biology: The Next Frontier for Bioinformatics
por: Likić, Vladimir A., et al.
Publicado: (2010)

Osteoporosis in the aging male: Treatment options
por: Tuck, Stephen P, et al.
Publicado: (2007)

Extracellular Vesicles as Drug Delivery Systems in Organ Transplantation: The Next Frontier
por: Spiers, Harry V. M., et al.
Publicado: (2023)

The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
por: Yin, Chao, et al.
Publicado: (2022)

Together to the next frontier
por: Lockyer, Nigel
Publicado: (2013)

Cone beam navigation bronchoscopy: the next frontier
por: Cheng, George Z., et al.
Publicado: (2020)

Norepinephrine: the next therapeutics frontier for Parkinson's disease
por: LeWitt, Peter A
Publicado: (2012)

Coronary Microcirculation: The Next Frontier in the Management of STEMI
por: Milasinovic, Dejan, et al.
Publicado: (2023)

Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis
por: Wang, Peng, et al.
Publicado: (2018)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

RANKL regulates male reproductive function
por: Blomberg Jensen, Martin, et al.
Publicado: (2021)

CPR and ECMO: The Next Frontier
por: Ambinder, Daniel I., et al.
Publicado: (2020)

Male osteoporosis
por: Bandeira, Leonardo, et al.
Publicado: (2022)

Targeting microbial quorum sensing: the next frontier to hinder bacterial driven gastrointestinal infections
por: Su, Ying, et al.
Publicado: (2023)

Bruton’s Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis
por: Garg, Neeta, et al.
Publicado: (2022)

The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer
por: Pellegrino, Nicole E., et al.
Publicado: (2022)

Clinical development of anti-RANKL therapy
por: Schwarz, Edward M, et al.
Publicado: (2007)

Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis
por: Abdi, Saba, et al.
Publicado: (2021)

The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
por: Weitzmann, M. Neale
Publicado: (2013)

Effects of RANKL-Targeted Therapy in Immunity and Cancer
por: Cheng, Michael L., et al.
Publicado: (2014)

Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males
por: Findlay, David, et al.
Publicado: (2008)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

Genes, emotions and gut microbiota: The next frontier for the gastroenterologist
por: Panduro, Arturo, et al.
Publicado: (2017)

The Evolution of Endovascular Therapy for Intracranial Aneurysms: Historical Perspective and Next Frontiers
por: Laurent, Dimitri, et al.
Publicado: (2022)

Bioinformatics: The Next Frontier of Metabolomics
por: Johnson, Caroline H., et al.
Publicado: (2014)

A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis
por: Liu, Changzhen, et al.
Publicado: (2015)

Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ERα to inhibit RANKL signaling
por: Wang, Keqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i6s11pcr7e497a2jq6de3g4nrt